title: Optimal DAPT duration: each in their own time.
authors.affiliation: Heart South Cardiovascular Group, Alabaster, AL and University of Alabama at Birmingham, Birmingham, AL, USA.
authors.forename: William B
authors.initials: WB
authors.lastname: Hillegass
authors.forename: Brigitta C
authors.initials: BC
authors.lastname: Brott
mesh_terms: D001241:Aspirin / Q000008:administration & dosage*; D054855:Drug-Eluting Stents; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000295:instrumentation*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage*; D058925:Receptors, Purinergic P2Y12 / Q000187:drug effects*
chemical_list: D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D001241:Aspirin